Related Experiment Video
Updated: Jun 3, 2026

Transuterine Fetal Tracheal Occlusion Model in Mice
Published on: February 5, 2021
Congenital diaphragmatic hernia: still a moving target
I Sluiter1, C P van de Ven, R M H Wijnen
1Intensive Care, Erasmus MC-Sophia, Rotterdam, The Netherlands.
Abstract:
The primary therapeutic target for congenital diaphragmatic hernia (CDH) patients has shifted from emergency surgical repair towards a non-operative emergency of the newborn treated by interdisciplinary teams. The increased understanding of the epidemiological and pathophysiological aspects of CDH have led to an improved knowledge and application of prenatal diagnosis, postnatal ventilation strategies, treatment of associated pulmonary hypertension and the role of extracorporeal membrane oxygenation therapy. In the surgical field, the perspectives have changed with delayed CDH repair, the introduction of minimally invasive surgery and use of prosthetic material for closure of large defects. With decreased mortality, long term multi-organ morbidity has increased in some survivors. In the near future, randomized controlled trials on different aspects of therapy will determine evidence-based optimal care.
Related Concept Videos
Hiatal Hernia
Pneumothorax II: Pathophysiology
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
Atelectasis II: Pathophysiology
Pneumothorax-II
Clinical Manifestations:
Pyloric Obstruction
